【摘要】：目的了解老年人慢性病基本藥物在亞太地區(qū)6個國家的價格及可及性現(xiàn)狀,為提高老年人慢性病基本藥物的可及性提供依據(jù)和政策建議。方法采用二手資料分析法,從WHO/HAI調(diào)查數(shù)據(jù)中提取相關(guān)藥品數(shù)據(jù),根據(jù)通貨膨脹/通貨緊縮和購買力平價轉(zhuǎn)化數(shù)據(jù)。結(jié)果 6個國家公立機構(gòu)老年人慢性病基本藥物通用藥及原研藥的可獲得性分別為5.0%~80.0%、1.8%~15.4%,私立機構(gòu)通用藥及原研藥可獲得性分別為11.7%~54.5%、10.0%~65.6%;公立機構(gòu)通用藥及原研藥的可負(fù)擔(dān)性分別為0~1.2倍、0~5.0倍日薪,私立機構(gòu)通用藥及原研藥的可負(fù)擔(dān)性分別為0.3~2.0倍、1.2~7.0倍日薪;公立機構(gòu)通用藥及原研藥的零售中位價格比(MPR)分別為0~32.88、0~79.13,私立機構(gòu)通用藥及原研藥的的零售MPR分別為0.92~46.21、13.84~103.75。結(jié)論 6個國家老年人慢性病用藥可獲得性較低,藥品價格高于國際水平,藥品可負(fù)擔(dān)性整體較差;6個國家的老年人慢性病基本藥物的可及性有待提高。
[Abstract]:Objective to investigate the price and accessibility of essential drugs for chronic diseases in the elderly in six countries in the Asia-Pacific region, and to provide evidence and policy suggestions for improving the accessibility of essential drugs for chronic diseases in the elderly. Methods the data of related drugs were extracted from WHO/HAI survey data by second-hand data analysis, and the conversion data of inflation / deflation and purchasing power parity (PPP) were obtained according to the data of inflation / deflation and purchasing power parity (PPP). Results the availability of general drugs and original drugs for chronic diseases in the elderly in six national public institutions was 5.0% 80.0%, 1.8% 15.4%, 11.7% 54.5% and 10.0% 65.6%, respectively. the availability of general drugs and original drugs in private institutions was 11.7% 54.5% and 10.0%, respectively. the availability of general drugs and original drugs was 5.0% 80.0%, 1.8% 15.4%, 11.7% 54.5% and 10.0% 65.6% respectively. The affordability of general drugs and original drugs in public institutions was 0 鹵1.2 times, 0 鹵5.0 times daily salary, the affordability of general drugs and original drugs in private institutions was 0.3 times 2.0 times and 1.2 times 7.0 times, the median retail price ratio of general drugs and original drugs in public institutions was 0: 32.8, 0 / 79.13, and the retail MPR of general drugs and original drugs in private institutions was 0.92% 46.21 and 13.84% 103.75, respectively. Conclusion the availability of drugs for chronic diseases of the elderly in 6 countries is low, the price of drugs is higher than the international level, and the affordability of drugs is poor as a whole, and the accessibility of essential drugs for chronic diseases of the elderly needs to be improved in 6 countries.
【作者單位】： 山東大學(xué)藥學(xué)院;山東大學(xué)醫(yī)藥衛(wèi)生管理學(xué)院國家衛(wèi)生與計劃生育委員會衛(wèi)生經(jīng)濟與政策研究重點實驗室(山東大學(xué));
【基金】：山東大學(xué)基本科研業(yè)務(wù)費自助項目國際合作項目(2015GJ10)
【分類號】：R95

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 王力;余蘇珍;王素珍;;提高我國基本藥物可及性的政策措施研究[J];中國衛(wèi)生經(jīng)濟;2011年07期

2 魏留軍;石磊;;我國基本藥物可及性研究現(xiàn)狀的分析[J];中國醫(yī)藥指南;2012年02期

3 王力;孫希望;余蘇珍;陳和利;王素珍;;江西省農(nóng)村居民基本藥物可及性調(diào)查與分析[J];中國衛(wèi)生經(jīng)濟;2012年12期

4 李海濤;;關(guān)于我國藥品可及性問題的探討[J];中國衛(wèi)生事業(yè)管理;2009年09期

5 李秦川;陳永法;顧政;;提高農(nóng)村偏遠(yuǎn)地區(qū)基本藥物可及性的思考[J];齊魯藥事;2010年03期

6 龔時薇;許q，

本文編號：2499564